The Philadelphia Flyers announced on Friday that forward Oskar Lindblom has been diagnosed with Ewing’s sarcoma. He is expected to miss the remainder of the season.
Ewing’s sarcoma is a rare form of cancer that grows in the bones or soft tissue around the bones. The overall five-year survival rate for localized Ewing’s sarcoma is 70 percent, according to the American Cancer Society.
General manager Chuck Fletcher wrote in a statement released Friday that Lindblom was diagnosed by specialists at the University of Pennsylvania.
“[Lindblom] will undergo further testing and evaluation next week and begin treatment immediately thereafter. He is not expected to return to play for the remainder of the season,” Fletcher wrote. “The Flyers will do everything possible to support Oskar and assist him in securing the best care available.
“Out of respect for Oskar and his family, the team will have no further comment at this time and asks that Oskar be afforded a period of privacy so that he may focus his efforts on his treatment and a return to full health.”
As per Flyers.com writer Bill Meltzer, Lindblom took a maintenance day on Monday and was not present for practice before missing Wednesday’s game with what was labeled an upper-body injury. It’s unclear whether or not that was related to his diagnosis.
In 30 games this season, the 23-year-old is tied for the team lead in goals with Travis Konecny (11) and has also added seven assists.
Lindblom was originally taken by the Flyers in the fifth round of the 2014 NHL draft and played his rookie season back in 2017-18. Through a total of 134 career games, he has 30 goals and 57 points.